您当前的位置:首页 > 重要报告
  • 1   2019-12-12 2005-2018结核病研究资金趋势 (编译服务:结核病防治)     
    摘要:

    The latest report from the Treatment Action Group (TAG) and the Stop TB Partnership, on global funding trends for TB research and development (R&D), presents new data on TB R&D funding in 2018 and analyzes trends in funding since 2005.

    The report - Tuberculosis Research Funding Trends, 2005-2018 - is a critical accountability tool and serves as a barometer of progress in raising support for the scientific innovation needed to eliminate TB.

    Global TB research funding totaled US$906 million in fiscal year 2018, an increase of $134 million from 2017. This is the highest level of funding ever recorded by TAG. TB scientists and their advocates should feel encouraged by three back-to-back years of increasing investments from 2016 to 2018. However, the 2018 funding figure still falls more than half-way short of the US$2 billion annual target set at 2018’s United Nations High Level Meeting on TB.

    "The US$134 million increase in TB research funding is cause for celebration and shows that the tireless efforts of TB partners around the world are getting results," said Lucica Ditiu, Executive Director of the Stop TB Partnership. "But this still leaves us short of the US$2 billion annual funding figure endorsed at the UN High-Level Meeting. Because we're off track, we'll now need to spend more each year to make up the deficit. We can’t afford to coast on recent momentum if we are serious about ending TB - it’s time to put our money where our mouths are".

    来源机构: | 点击量:3790
  • 2   2019-12-12 全球药物设施诊断目录2019年10月 (编译服务:结核病防治)     
    摘要:

    05 December 2019 I Geneva, Switzerland – The Stop TB Partnership’s Global Drug Facility (GDF) has expanded its Diagnostics Catalog by adding an IGRA (interferon-gamma release assay) test for latent TB infection. The products required to run the QuantiFERON-TB Gold Plus (QFT-Plus) IGRA are now available at a GDF-negotiated price of $15.90 per test by the manufacturer Qiagen (Hilden, Germany). This price is offered to any public sector or not-for-profit buyer in low- and middle-income countries when procuring through GDF. For the full listing of products, see the GDF Diagnostics Catalog.

    来源机构: | 点击量:3758
  • 3   2019-12-12 2018-2022年全球终止结核病计划 (编译服务:结核病防治)     
    摘要:

    The Global Plan to End TB 2018-2022 is a costed plan and roadmap for a concerted response to tuberculosis (TB), aligned with the United Nations (UN) Political Declaration on TB. It provides an estimate of the resources needed to achieve the targets and commitments set at the UN High-Level Meeting (UNHLM) on TB in September 2018. It provides an estimate for the resources needed to achieve these targets by 2022.

    The updated Global Plan for 2018-2022 is deliberately aligned to the time frame of the UNHLM targets, making it a tool for advocacy, resource mobilization, civil society, and community empowerment and accountability on the UNHLM targets and commitments.

    It is centered on strong political leadership to achieve the UNHLM targets and commitments.

    It breaks down the global targets of UNHLM into country shares in order to ensure that countries deliver on their commitments and collectively, the world reaches the agreed targets

    It provides an estimate of the resources needed to achieve the UNHLM TB targets and commitments, both for TB care and prevention, and for research into new tools.

    It highlights the need for a rights-based, people-centered approach community-based and gender-responsive TB services based.

    来源机构: | 点击量:3774
  • 4   2019-10-29 2019全球结核病报告 (编译服务:结核病防治)     
    摘要:

    1997年至今,世界卫生组织(the World HealthOrganization, WHO)每年都会发布一次全球结核病报告。在全球的承诺和策略背景下,该报告的目的是对结核病流行情况及全球、各地区和国家应对结核病流行的进展情况进行最全面和最新的评估。本次报告的撰写主要参考了WHO年度收集的数据和其他多边机构维护的数据库。2019年,202个国家和地区报告了相关数据,这些国家和地区的结核病病例数量占世界人口与估算结核病例数量的99%以上。

    来源机构: WHO | 点击量:2287
  • 5   2018-08-29 肺结核影像学及分级诊断专家共识 (编译服务:结核病防治)     
    摘要:

    为解决我国结核病防治工作重点和难点问题,国务院办公厅和国家卫生计生委办公厅分别下发了关于推进分级诊疗制度建设的指导意见和关于开展结核病分级诊疗和综合防治服务模式试点工作的通知等文件。作为结核病诊断的重要组成部分,影像学诊断在结核病分级诊断中的地位和作用不言而喻。为规范肺结核的影像学诊断,提高相关医务人员肺结核的临床影像诊断与鉴别诊断水平,推动全国肺结核分级诊断工作有序进行,特组织有关专家,制定本共识,希望为肺结核分级诊断做出贡献。

    来源机构: 中华医学会放射学分会 | 点击量:5558
  • 6   2018-08-29 肺结核影像学及分级诊断专家共识 (编译服务:结核病防治)     
    摘要:

    为解决我国结核病防治工作重点和难点问题,国务院办公厅和国家卫生计生委办公厅分别下发了关于推进分级诊疗制度建设的指导意见和关于开展结核病分级诊疗和综合防治服务模式试点工作的通知等文件。作为结核病诊断的重要组成部分,影像学诊断在结核病分级诊断中的地位和作用不言而喻。为规范肺结核的影像学诊断,提高相关医务人员肺结核的临床影像诊断与鉴别诊断水平,推动全国肺结核分级诊断工作有序进行,特组织有关专家,制定本共识,希望为肺结核分级诊断做出贡献。

    来源机构: 中华医学会放射学分会 | 点击量:30
  • 7   2018-04-18 2017全球结核病报告 (编译服务:结核病防治)     
    摘要:

    总体而言,结核病给全球人民带来的负担仍然很重,消除该疾病的进展速度不够快,难以达到目标,或在缩小长期的差距方面取得重大进展。结核病是全球第九大致死疾病,甚至高于艾滋病。2016年,有约1040万人因结核病而患病,其中90%为成人,65%为男性,10%为携带艾滋病毒的人。56%的病例出现在五个国家,即印度、印度尼西亚、中国、菲律宾和巴基斯坦。全球范围内,结核病死亡率每年下降约3%,结核病发病率每年下降约2%,结核病患者死亡率为16%。到2020年,这些数字每年需要分别提高4-5%和10%,以达到“结核病战略”第一个的里程碑。

    来源机构: WHO | 点击量:2185
  • 8   2017-07-11 学校结核病防控工作规范(2017版) (编译服务:结核病防治)     
    摘要:
    为进一步加强学校结核病防控工作,根据《传染病防治法》和《突发公共卫生事件应急条例》的规定,国家卫生计生委会同教育部对《学校结核病防控工作规范(试行)》进行了修订完善,于2017年6月26日制定《学校结核病防控工作规范(2017版)》。
    来源机构: 国家卫生计生委疾病预防控制局 | 点击量:1412
  • 9   2017-07-07 中国结核病病理学诊断专家共识 (编译服务:结核病防治)     
    摘要:
    病理学诊断是微生物学之外最重要的结核病确诊途径,在痰菌阴性的肺结核及肺外结核的诊断中发挥着非常重要的作用。近年来,随着分子病理学技术的快速发展,结核病的病理学检查可为临床提供更明确的诊断,如结核病与非结核分枝杆菌病的鉴别诊断及耐药结核病的诊断等。 为了促进国内结核病病理学诊断水平的提高,增进临床医生对结核病病理诊断的认识,中华医学会结核病学分会组织病理学及临床领域专家共同探讨了结核病病理学诊断的相关问题,最终形成该共识。
    来源机构: 中华结核和呼吸杂志 | 点击量:1757
  • 摘要:

    结核病(呼吸系统)_2017年新版JCR高影响因子期刊

    来源机构: | 点击量:1271